5 Best Biotech Stocks to Buy Under $10
Ovid Therapeutics Inc. (NASDAQ:OVID) is an emerging biotech company that designs therapies for epilepsies, seizure-related disorders, and neurological disorders.
Ardelyx Inc. (ARDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 14,858,000 | $17,681 | 0.8% | |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 5,339,065 | $6,353 | 0.08% | |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 4,000,000 | $4,760 | 0.01% | |
| 4. | Ikarian Capital Neil Shahrestani | 3,178,825 | $3,784 | +90% | 0.75% |
| 5. | Point72 Asset Management Steve Cohen | 1,852,081 | $2,204 | -63% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.76 | 567,000 | Director | 1,166,765 | 2022-11-17 | Filing | |
| $0.62 | 3,000 | Officer | 91,418 | 2022-08-31 | Filing | |
| $0.62 | 3,000 | Officer | 92,369 | 2022-08-31 | Filing | |
| $0.62 | 3,000 | Officer | 263,549 | 2022-08-31 | Filing | |
| $0.62 | 3,000 | Officer | 245,441 | 2022-08-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.95 | 471 | Officer | 88,885 | 2022-11-22 | Filing | |
| $1.95 | 2 | Officer | 89,356 | 2022-11-22 | Filing | |
| $1.94 | 11 | Officer | 89,358 | 2022-11-22 | Filing | |
| $1.95 | 1,405 | Officer | 300,994 | 2022-11-22 | Filing | |
| $1.95 | 33 | Officer | 302,399 | 2022-11-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 22,483 | $64,077 | 0.01% | |
| 2. | 21,004 | $59,861 | 0% | |
| 3. | 16,720 | $47,652 | 0% | |
| 4. | 15,504 | $44,186 | 0% | |
| 5. | 13,000 | $37,050 | 0.01% |
News See All
5 Best Penny Stocks to Buy Now
Geron Corporation (NASDAQ:GERN), located in Foster City, California, is a biotechnology company. The company makes cancer-treating drugs that block telomeras.
5 Penny Stocks With Biggest Upside
Denison Mines Corp. (NYSE:DNN) engages in the acquisition, exploration, development, extraction, processing, selling off, and investing of uranium properties in Canada.
10 Penny Stocks That Can Grow Big in 2023
Numerous speculative asset classes, including cryptocurrency and penny stocks, have suffered at the hands of economic uncertainty this year.
5 Best High Volume Penny Stocks to Buy Now
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United...
5 Best Medical Stocks Under $5
Geron Corporation (NASDAQ:GERN) is a biopharmaceutical company that is involved in the development of drugs for advanced blood cancers.
10 Penny Stocks Poised To Explode
The ongoing bloodbath in the stock market that has been compounded by high inflation and monetary policy tightening has left investors fleeing to safe assets and the market shuddering in the aftermath...
5 Best Biotech Penny Stocks To Buy Now
NuCana plc (NASDAQ:NCNA) is a British biotech firm which develops drug therapies to treat various forms of cancer.
5 Penny Stocks to Buy in March
CTI BioPharma Corp. (NASDAQ:CTIC) is a biopharmaceutical company based in the United States, developing therapies for blood-related cancers.
5 Micro-Cap Stocks to Buy According to Hedge Funds
In this article, we will discuss 5 micro-cap stocks to buy according to hedge funds.
Billionaire Hedge Funds
